CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines The Prevalence of Myocardial Bridging Associated with Coronary Endothelial Dysfunction in Patients with Chest Pain and Non-Obstructive Coronary Artery Disease Myocardial bridging: contemporary understanding of pathophysiology with implications for diagnostic and therapeutic strategies Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA) When, where, and how to target vascular inflammation in the post-CANTOS era? Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes 2019 ACC/AHA/ASE Advanced Training Statement on Echocardiography (Revision of the 2003 ACC/AHA Clinical Competence Statement on Echocardiography): A Report of the ACC Competency Management Committee

Original Research2021 May 6. doi: 10.1002/ehf2.13410.

JOURNAL:ESC Heart Fail. Article Link

Right ventricular expression of NT-proBNP adds predictive value to REVEAL score in patients with pulmonary arterial hypertension

WT Chang, JY Shih, ChS Hong et al. Keywords: Group I PAH; HF hospitalization; NT-proBNP; RV expression.

Full Text PDF